Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.56
(0.0%)
EUR 2.56
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 332.44 Million EUR | 3.5% |
| 2022 | 321.19 Million EUR | -1.16% |
| 2021 | 324.97 Million EUR | 2.47% |
| 2020 | 317.15 Million EUR | 1.13% |
| 2019 | 313.61 Million EUR | 42.76% |
| 2018 | 219.67 Million EUR | 8.03% |
| 2017 | 203.33 Million EUR | -1.12% |
| 2016 | 205.63 Million EUR | 9.93% |
| 2015 | 187.05 Million EUR | 3.49% |
| 2014 | 180.74 Million EUR | 115.77% |
| 2013 | 83.76 Million EUR | -14.58% |
| 2012 | 98.05 Million EUR | -40.71% |
| 2011 | 165.37 Million EUR | -9.67% |
| 2010 | 183.08 Million EUR | -8.54% |
| 2009 | 200.18 Million EUR | -34.9% |
| 2008 | 307.49 Million EUR | -3.17% |
| 2007 | 317.55 Million EUR | 9.89% |
| 2006 | 288.97 Million EUR | 84.77% |
| 2005 | 156.39 Million EUR | 197.13% |
| 2004 | 52.63 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 343.6 Million EUR | 3.36% |
| 2024 Q3 | 346.86 Million EUR | -2.57% |
| 2024 Q2 | 356.03 Million EUR | 3.62% |
| 2023 Q3 | 338.88 Million EUR | 0.42% |
| 2023 Q4 | 332.44 Million EUR | -1.9% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 FY | 332.44 Million EUR | 3.5% |
| 2023 Q2 | 337.47 Million EUR | 0.0% |
| 2022 Q4 | 321.19 Million EUR | -2.31% |
| 2022 FY | 321.19 Million EUR | -1.16% |
| 2022 Q3 | 328.8 Million EUR | 0.0% |
| 2022 Q2 | 328.79 Million EUR | 0.0% |
| 2021 Q2 | 335.7 Million EUR | 3.06% |
| 2021 Q1 | 325.72 Million EUR | 2.7% |
| 2021 FY | 324.97 Million EUR | 2.47% |
| 2021 Q4 | 324.97 Million EUR | -0.48% |
| 2021 Q3 | 326.53 Million EUR | -2.73% |
| 2020 Q2 | 325.47 Million EUR | 1.04% |
| 2020 Q4 | 317.15 Million EUR | -0.28% |
| 2020 Q3 | 318.05 Million EUR | -2.28% |
| 2020 FY | 317.15 Million EUR | 1.13% |
| 2020 Q1 | 322.12 Million EUR | 2.71% |
| 2019 Q2 | 264.74 Million EUR | 11.29% |
| 2019 Q4 | 313.61 Million EUR | 4.02% |
| 2019 FY | 313.61 Million EUR | 42.76% |
| 2019 Q1 | 237.88 Million EUR | 8.29% |
| 2019 Q3 | 301.49 Million EUR | 13.88% |
| 2018 Q3 | 217.38 Million EUR | 2.64% |
| 2018 Q1 | 209.71 Million EUR | 3.13% |
| 2018 FY | 219.67 Million EUR | 8.03% |
| 2018 Q4 | 219.67 Million EUR | 1.05% |
| 2018 Q2 | 211.78 Million EUR | 0.99% |
| 2017 Q1 | 201.58 Million EUR | -1.97% |
| 2017 FY | 203.33 Million EUR | -1.12% |
| 2017 Q2 | 196.44 Million EUR | -2.55% |
| 2017 Q4 | 203.33 Million EUR | 5.31% |
| 2017 Q3 | 193.08 Million EUR | -1.71% |
| 2016 Q4 | 205.63 Million EUR | 6.64% |
| 2016 FY | 205.63 Million EUR | 9.93% |
| 2016 Q1 | 190.84 Million EUR | 2.03% |
| 2016 Q2 | 192.51 Million EUR | 0.88% |
| 2016 Q3 | 192.82 Million EUR | 0.16% |
| 2015 Q4 | 187.05 Million EUR | 1.39% |
| 2015 Q3 | 184.49 Million EUR | 0.5% |
| 2015 FY | 187.05 Million EUR | 3.49% |
| 2015 Q2 | 183.56 Million EUR | -2.25% |
| 2015 Q1 | 187.78 Million EUR | 3.9% |
| 2014 Q2 | 85.06 Million EUR | -4.16% |
| 2014 Q3 | 86.87 Million EUR | 2.13% |
| 2014 FY | 180.74 Million EUR | 115.77% |
| 2014 Q4 | 180.74 Million EUR | 108.05% |
| 2014 Q1 | 88.75 Million EUR | 5.96% |
| 2013 Q2 | 88.05 Million EUR | -14.18% |
| 2013 FY | 83.76 Million EUR | -14.58% |
| 2013 Q4 | 83.76 Million EUR | -4.93% |
| 2013 Q3 | 88.11 Million EUR | 0.06% |
| 2013 Q1 | 102.6 Million EUR | 4.64% |
| 2012 FY | 98.05 Million EUR | -40.71% |
| 2012 Q2 | 150.44 Million EUR | -12.08% |
| 2012 Q3 | 158.39 Million EUR | 5.29% |
| 2012 Q4 | 98.05 Million EUR | -38.09% |
| 2012 Q1 | 171.1 Million EUR | 3.46% |
| 2011 FY | 165.37 Million EUR | -9.67% |
| 2011 Q4 | 165.37 Million EUR | 0.0% |
| 2011 Q2 | 178.38 Million EUR | 0.0% |
| 2010 Q1 | 214.12 Million EUR | 0.0% |
| 2010 FY | 183.08 Million EUR | -8.54% |
| 2010 Q2 | 200.65 Million EUR | -6.29% |
| 2009 FY | 200.18 Million EUR | -34.9% |
| 2008 FY | 307.49 Million EUR | -3.17% |
| 2007 FY | 317.55 Million EUR | 9.89% |
| 2006 FY | 288.97 Million EUR | 84.77% |
| 2005 FY | 156.39 Million EUR | 197.13% |
| 2004 FY | 52.63 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Almirall, S.A. | 2.37 Billion EUR | 86.002% |
| Faes Farma, S.A. | 776.02 Million EUR | 57.161% |